Dong Dai

Dong Dai, PhD, MBA, is an experienced professional in health economics and outcomes research, currently serving as Director of Global HEOR at Daiichi Sankyo, Inc. since August 2021. Previous roles include Senior RWE Scientist at Novartis Oncology and Associate Director in Health Economics & Outcomes Research at Novartis. Dong Dai has a background in advanced analytics, having worked as a Senior Manager at QuintilesIMS and Manager at IMS Health, where innovative statistical modeling and machine learning applications were developed. Academic credentials include a PhD in Statistics from Rutgers University, an MBA from Drexel University, and a Bachelor's degree in Mathematics and Statistics from the University of Science and Technology of China.